Johnson & Johnson (JNJ) Is Becoming a Growth Stock. Does AbbVie (ABBV) Make JNJ Look Expensive?
· insidermonkey.com
Johnson & Johnson (NYSE:JNJ) is starting to look less like a defensive healthcare giant and more like a growth story.
Johnson & Johnson is starting to look less like a defensive healthcare giant and more like a growth story. The harder question is how much investors should pay ...